Resolution of methotrexate-induced Epstein-Barr virus-associated mucocutaneous ulcer.
Department of Haematology, St James's University Hospital, Leeds, UK.
Nandini
N
Sadasivam
Roderick J
RJ
Johnson
Roger G
RG
Owen
D000368:Aged; D020031:Epstein-Barr Virus Infections / Q000150:complications* / Q000276:immunology; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008232:Lymphoproliferative Disorders / Q000276:immunology / Q000473:pathology / Q000821:virology; D008297:Male; D008727:Methotrexate / Q000009:adverse effects*; D019226:Oral Ulcer / Q000276:immunology / Q000473:pathology / Q000821:virology*
D007166:Immunosuppressive Agents; D008727:Methotrexate